SC
ANNX icon

Stempoint Capital’s Annexon ANNX Stock Holding History

Stempoint Capital’s Portfolio ANNX Stock Details ANNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-605,117
Closed -$4.34M – 46
2024
Q1 		$4.34M Sell
605,117
-1,983
-0.3% -$10.3K 1.15% 27
2023
Q4 		$2.76M Buy
+607,100
New +$1.5M 0.74% 45

Other funds holding ANNX

BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AIM
Alerce Investment Management Chicago, Illinois $56.8M AUM 31.17% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Stempoint Capital's ANNX Position: Q2 2024 in Review

Stempoint Capital sold out of Annexon (ANNX) in Q2 2024, closing a stake of 605,117 shares — an estimated $4.34M sold.

Stempoint Capital first reported a position in ANNX in Q4 2023 and held it in 2 quarters. The position peaked at $4.34M in Q1 2024. 140 funds tracked by Wall St. Rank hold ANNX as of Q2 2024.

  • Stempoint Capital reported no remaining Annexon position as of Q2 2024 after selling out during the quarter.
  • Stempoint Capital sold 605,117 Annexon shares in Q2 2024, an estimated $4.34M.
  • Stempoint Capital first reported a position in Annexon in Q4 2023 and held it in 2 quarters.
  • Stempoint Capital's Annexon position peaked at $4.34M in Q1 2024.
  • 140 funds tracked by Wall St. Rank held Annexon as of Q2 2024.

Based on Stempoint Capital's 13F filing for Q2 2024, filed 13 Aug 2024.